Champions Oncology, Inc.
CSBR Healthcare Biotechnology
Champions Oncology, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $59.4 million, up 4.36% from fiscal 2025. In the quarter to July 2026, revenue grew 8.84%, EPS was flat and free cash flow fell 198.7%, each against the same quarter a year earlier.
Follow CSBR
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
Net Income |
(0.43) | (0.67) | (0.28) | 0.24 |
+8 more quarters Free account |
Depreciation & Amortization |
0.31 | 0.32 | 0.34 | 0.36 | |
Non Cash Items (Other) |
1.04 | 0.76 | 0.80 | 0.68 | |
Accounts Receivable Change |
(0.41) | (1.18) | (0.50) | (2.08) | |
Accounts Payable Change |
(1.42) | 1.27 | (0.44) | 1.31 | |
Change in payables and accrued liability |
0.08 | (0.75) | 1.16 | 0.39 | |
Change in other assets and liabilities |
0.34 | (1.75) | (2.43) | (2.63) | |
Operating Cash Flow |
(0.49) | (2.00) | (1.34) | (1.73) | |
Capital expenditures |
(0.05) | (0.24) | (0.01) | (0.24) | |
Investing cash flow |
(0.05) | (0.24) | (0.01) | (0.24) | |
Repayment/Issuance of Debt (Net) |
(0.02) | (0.02) | (0.04) | (0.04) | |
Equity Repurchase (Common, Net) |
0.05 | 0.00 | 0.00 | 0.21 | |
Financing cash flow |
0.03 | (0.02) | (0.04) | 0.17 | |
Change in Cash |
(0.51) | (2.25) | (1.39) | (1.81) | |
Beginning Cash |
4.87 | 0.00 | 0.00 | 0.00 | |
Ending Cash |
4.36 | (2.25) | (1.39) | (1.81) | |
Stock Based Compensation |
0.77 | 0.36 | 0.42 | 0.25 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
(1.42) | (2.41) | (2.21) | (3.00) | |
Issuance/Purchase of Shares |
0.05 | 0.00 | 0.00 | 0.21 |